June 8, 2017
Japanese generic major Sawai Pharmaceutical said on June 7 that the US FDA has accepted its abbreviated new drug application (ANDA) for its generic version of Biogen’s multiple sclerosis drug Tecfidera (dimethyl fumarate) - its third US ANDA filing after...read more